rethinkPeptides Search
Menu
Research citation

Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.

Pflugers Archiv : European journal of physiology, 476(5), 779-795

Citation

Moghazy, Hoda M; Abdelhaliem, Nesreen G; Mohammed, Sherine Ahmed; Hassan, Asmaa; Abdelrahman, Amany. (2024). Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.. Pflugers Archiv : European journal of physiology, 476(5), 779-795. https://doi.org/10.1007/s00424-024-02933-0